Full-length major circulating human kisspeptin isoform
PRODUCT PROFILE
Kisspeptin-54
£63.00
Kisspeptin-54 is full-length major circulating human kisspeptin isoform. Researchers examine it in relation to gnrh/lh triggering, oocyte maturation and reproductive-axis physiology.
Longer-lived isoform with direct human oocyte-maturation research, unlike the shorter kisspeptin-10.
- Evidence stageClinical research
- AvailabilityUnavailable
- Batch recordPublished after verification
- DispatchConfirmed at checkout
Out of stock
Ask about availabilityPRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
Kisspeptin-54 is full-length major circulating human kisspeptin isoform. Researchers examine it in relation to gnrh/lh triggering, oocyte maturation and reproductive-axis physiology.
Research focus+
Researchers study how it activates reproductive hormones and supports egg-maturation research. It lasts longer than Kisspeptin-10, but remains a specialist clinical-research material.
How the mechanism differs+
Activates KISS1R/GPR54 with a more sustained in-vivo LH response than kisspeptin-10.
Evidence and limitations+
Human IVF and reproductive-endocrinology studies include phase 2 work, but it remains investigational.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers study how it activates reproductive hormones and supports egg-maturation research. It lasts longer than Kisspeptin-10, but remains a specialist clinical-research material.
Activates KISS1R/GPR54 with a more sustained in-vivo LH response than kisspeptin-10.
Longer-lived isoform with direct human oocyte-maturation research, unlike the shorter kisspeptin-10.
Human IVF and reproductive-endocrinology studies include phase 2 work, but it remains investigational.
Educational research context only. This information is not dosage, administration or personal-use guidance.



